M90.652

Clinical Causes: Genetic factors: Family history of Paget's disease increases risk. Viral infections: Certain viruses have been implicated in triggering abnormal bone remodeling. Environmental factors: Some environmental exposures may influence disease development. Age: More common in older adults, indicating age-related bone turnover changes. Neoplastic processes: Underlying neoplastic diseases may contribute to the development of osteitis deformans in affected bones.

Key Symptoms: Bone pain: Often localized and worsens at night or with activity. Bone deformity: Noticeable thickening or deformity of the affected bone. Swelling or tenderness over the area. Joint stiffness or reduced mobility, if the joint near the affected bone is involved. Potential fractures: Weakened bones are more susceptible to breaks. Other possible symptoms include fatigue and, in some cases, hearing loss if the skull is involved.

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, imaging tests, and laboratory studies: - X-rays can reveal characteristic bone changes such as thickening, deformity, and sclerosis. - Bone scans help identify regions of high bone turnover. - Blood tests measuring alkaline phosphatase levels are often elevated in active disease. - Bone biopsies may be performed in uncertain cases to confirm the diagnosis and assess tissue pathology. - Additional tests are conducted if neoplastic conditions are suspected or present.

Treatment Protocols: Management of osteitis deformans aims to control symptoms, reduce bone turnover, and prevent complications: - Bisphosphonates are the primary medications used to inhibit abnormal bone resorption. - Pain relievers, including NSAIDs, can help alleviate discomfort. - Regular monitoring through imaging and blood tests to assess disease activity. - Physical therapy may be recommended to maintain mobility and strengthen muscles. - In some cases, surgical intervention may be necessary to correct severe deformities or treat fractures. - Addressing underlying neoplastic or other associated conditions is an integral part of comprehensive care.